BioTwin ApS: Financial statements 2025
CVR: 44030179
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioTwin ApS (CVR 44030179) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -35,651 and a net result of DKK 36,954,257 compared with DKK 384 the year before. Equity in the 2025 report amounted to DKK 41,790,036. The solvency ratio was 98.5%.
- Revenue
- DKK 0
- Gross Profit
- DKK -35,651
- Profit/Loss
- DKK 36,954,257
- Equity
- DKK 41,790,036
- Total Assets
- DKK 42,429,297
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -36 t. | 37 mio. | 41.8 mio. | 0 |
| 2024 | 0 | 0 | 384 | 4.8 mio. | - |
How creditworthy is BioTwin ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioTwin ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 384.
About BioTwin ApS
BioTwin ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Sune Schmølker. The company is owned by Sune Schmølker. In 2025, the company reported a gross profit of DKK -35,651 and a net result of DKK 36,954,257 compared with DKK 384 the year before. Equity in the 2025 report amounted to DKK 41,790,036.